USPTO 2015–2025 USPTO PatentsView Foreign Corporation

West Pharma. Services IL, Ltd.

USPTO PatentsView assignee record — 117 granted patents across 13 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

117
Total patents granted
13
CPC technology areas
13.7
Avg claims per patent
+190%
5-year filing velocity

The verdict

West holds 117 US patents across 13 technology areas — rank #3,215 of 50,000 tracked assignees.

#3,215
of 50,000 US assignees by volume
Top 32%
by Innovation Score (41.9/100)
13.7
avg claims per patent
+190%
filing velocity, last 5 yrs

Portfolio overview

West Pharma. Services IL, Ltd. has been granted 117 US utility patents between 2018 and 2025, placing West Pharma. Services IL, Ltd. at rank #3,215 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.7 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, West Pharma. Services IL, Ltd. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 41.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 87 grants, compared with 30 in the 2015–2019 window — a +190% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. West Pharma. Services IL, Ltd.'s 13.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark West Pharma. Services IL, Ltd. against peers pursuing similar technology classes.

How does West compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows West holds 117 patents — placing it at rank #3,215 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

West's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

0510152025 20182019202020212022202320242025 5
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
West Pharma. Services IL, Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 10 8.5%
2019 20 17.1%
2020 22 18.8%
2021 19 16.2%
2022 14 12.0%
2023 16 13.7%
2024 11 9.4%
2025 5 4.3%

Which technologies does West Pharma. Services IL, Ltd. patent most?

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,215

Across all tracked assignees

Innovation Score

41.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does West Pharma. Services IL, Ltd. hold?
West Pharma. Services IL, Ltd. holds 117 US granted patents filed between 2018 and 2025, spanning 13 technology areas.
What is West Pharma. Services IL, Ltd.'s Innovation Score?
West Pharma. Services IL, Ltd. has an Innovation Score of 41.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does West Pharma. Services IL, Ltd. focus on?
West Pharma. Services IL, Ltd.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 92 patents. The company has filed patents in 13 CPC subclasses total.
Is West Pharma. Services IL, Ltd.'s patent filing rate increasing or decreasing?
West Pharma. Services IL, Ltd.'s recent filing velocity is +190% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for West Pharma. Services IL, Ltd.'s patents?
West Pharma. Services IL, Ltd.'s patents average 13.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the West Pharma. Services IL, Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope